Mangalam Organics（MANORG）株式概要マンガラム・オーガニックス社はインド国内および国際的に化学薬品を製造・販売している。 詳細MANORG ファンダメンタル分析スノーフレーク・スコア評価2/6将来の成長0/6過去の実績4/6財務の健全性2/6配当金0/6報酬株価収益率（ 19 x） Indian市場（ 23.8 x）を下回っています。過去1年間で収益は104.5%増加しました リスク分析利払いは収益で十分にカバーされない 過去5年間で収益は年間37.7%減少しました。 Indian市場と比較した過去 3 か月間の株価の変動意味のある時価総額がありません ( ₹5B )すべてのリスクチェックを見るMANORG Community Fair Values Create NarrativeSee what others think this stock is worth. Follow their fair value or set your own to get alerts.NEW493,723 membersJoin community and earn perksGain real feedbackFrom our editorial team, personally. Not silence.Grow your followingReal investors. The kind who actually invest, not scroll past.Unlock free accessFree premium subscription for consistent and quality authors.Learn moreCreate NarrativeBLINROAG493,723 investors already sharing narrativesYour Fair Value₹Current Price₹571.4092.6% 割高 内在価値ディスカウントGrowth estimate overAnnual revenue growth rate5 Yearstime period%/yrDecreaseIncreasePastFuture-272m9b2016201920222025202620282031Revenue ₹8.7bEarnings ₹358.3mAdvancedSet Fair ValueView all narrativesMangalam Organics Limited 競合他社Beezaasan ExplotechSymbol: BSE:544369Market cap: ₹5.0bRubfila InternationalSymbol: NSEI:RUBFILAMarket cap: ₹4.0bPOCL EnterprisesSymbol: BSE:539195Market cap: ₹5.2bLords Chloro AlkaliSymbol: BSE:500284Market cap: ₹4.2b価格と性能株価の高値、安値、推移の概要Mangalam Organics過去の株価現在の株価₹571.4052週高値₹637.8552週安値₹356.25ベータ0.521ヶ月の変化1.41%3ヶ月変化23.45%1年変化16.16%3年間の変化23.17%5年間の変化n/aIPOからの変化-37.03%最新ニュースNew Risk • Jul 03New major risk - Share price stabilityThe company's share price has been highly volatile over the past 3 months. It is more volatile than 90% of Indian stocks, typically moving 9.4% a week. This is considered a major risk. Share price volatility increases the risk of potential losses in the short-term as the stock tends to have larger drops in price more frequently than other stocks. It may also indicate the stock is highly sensitive to market conditions or economic conditions rather than being sensitive to its own business performance, which may also be inconsistent. Currently, the following risks have been identified for the company: Major Risks Interest payments are not well covered by earnings (2.1x net interest cover). Share price has been highly volatile over the past 3 months (9.4% average weekly change). Earnings have declined by 38% per year over the past 5 years. Minor Risk Market cap is less than US$100m (₹4.58b market cap, or US$48.1m).Valuation Update With 7 Day Price Move • Jun 19Investor sentiment improves as stock rises 20%After last week's 20% share price gain to ₹563, the stock trades at a trailing P/E ratio of 18.5x. Average trailing P/E is 21x in the Chemicals industry in India. Total returns to shareholders of 34% over the past three years.Valuation Update With 7 Day Price Move • Jun 05Investor sentiment deteriorates as stock falls 19%After last week's 19% share price decline to ₹469, the stock trades at a trailing P/E ratio of 16.1x. Average trailing P/E is 21x in the Chemicals industry in India. Total returns to shareholders of 13% over the past three years.Reported Earnings • May 31Full year 2026 earnings released: EPS: ₹29.64 (vs ₹14.71 in FY 2025)Full year 2026 results: EPS: ₹29.64 (up from ₹14.71 in FY 2025). Revenue: ₹6.27b (up 18% from FY 2025). Net income: ₹257.6m (up 105% from FY 2025). Profit margin: 4.1% (up from 2.4% in FY 2025). The increase in margin was driven by higher revenue. Over the last 3 years on average, earnings per share has increased by 108% per year but the company’s share price has only increased by 10% per year, which means it is significantly lagging earnings growth.お知らせ • May 25Mangalam Organics Limited to Report Q4, 2026 Results on May 29, 2026Mangalam Organics Limited announced that they will report Q4, 2026 results on May 29, 2026New Risk • May 09New minor risk - Share price stabilityThe company's share price has been volatile over the past 3 months. It is more volatile than 75% of Indian stocks, typically moving 8.7% a week. This is considered a minor risk. Share price volatility indicates the stock is highly sensitive to market conditions or economic conditions rather than being sensitive to its own business performance, which may also be inconsistent. It also increases the risk of potential losses in the short term as the stock tends to have larger drops in price more frequently than other stocks. Currently, the following risks have been identified for the company: Major Risks Interest payments are not well covered by earnings (1.4x net interest cover). Earnings have declined by 42% per year over the past 5 years. Minor Risks Share price has been volatile over the past 3 months (8.7% average weekly change). Market cap is less than US$100m (₹5.14b market cap, or US$54.4m).最新情報をもっと見るRecent updatesNew Risk • Jul 03New major risk - Share price stabilityThe company's share price has been highly volatile over the past 3 months. It is more volatile than 90% of Indian stocks, typically moving 9.4% a week. This is considered a major risk. Share price volatility increases the risk of potential losses in the short-term as the stock tends to have larger drops in price more frequently than other stocks. It may also indicate the stock is highly sensitive to market conditions or economic conditions rather than being sensitive to its own business performance, which may also be inconsistent. Currently, the following risks have been identified for the company: Major Risks Interest payments are not well covered by earnings (2.1x net interest cover). Share price has been highly volatile over the past 3 months (9.4% average weekly change). Earnings have declined by 38% per year over the past 5 years. Minor Risk Market cap is less than US$100m (₹4.58b market cap, or US$48.1m).Valuation Update With 7 Day Price Move • Jun 19Investor sentiment improves as stock rises 20%After last week's 20% share price gain to ₹563, the stock trades at a trailing P/E ratio of 18.5x. Average trailing P/E is 21x in the Chemicals industry in India. Total returns to shareholders of 34% over the past three years.Valuation Update With 7 Day Price Move • Jun 05Investor sentiment deteriorates as stock falls 19%After last week's 19% share price decline to ₹469, the stock trades at a trailing P/E ratio of 16.1x. Average trailing P/E is 21x in the Chemicals industry in India. Total returns to shareholders of 13% over the past three years.Reported Earnings • May 31Full year 2026 earnings released: EPS: ₹29.64 (vs ₹14.71 in FY 2025)Full year 2026 results: EPS: ₹29.64 (up from ₹14.71 in FY 2025). Revenue: ₹6.27b (up 18% from FY 2025). Net income: ₹257.6m (up 105% from FY 2025). Profit margin: 4.1% (up from 2.4% in FY 2025). The increase in margin was driven by higher revenue. Over the last 3 years on average, earnings per share has increased by 108% per year but the company’s share price has only increased by 10% per year, which means it is significantly lagging earnings growth.お知らせ • May 25Mangalam Organics Limited to Report Q4, 2026 Results on May 29, 2026Mangalam Organics Limited announced that they will report Q4, 2026 results on May 29, 2026New Risk • May 09New minor risk - Share price stabilityThe company's share price has been volatile over the past 3 months. It is more volatile than 75% of Indian stocks, typically moving 8.7% a week. This is considered a minor risk. Share price volatility indicates the stock is highly sensitive to market conditions or economic conditions rather than being sensitive to its own business performance, which may also be inconsistent. It also increases the risk of potential losses in the short term as the stock tends to have larger drops in price more frequently than other stocks. Currently, the following risks have been identified for the company: Major Risks Interest payments are not well covered by earnings (1.4x net interest cover). Earnings have declined by 42% per year over the past 5 years. Minor Risks Share price has been volatile over the past 3 months (8.7% average weekly change). Market cap is less than US$100m (₹5.14b market cap, or US$54.4m).分析記事 • May 05Does Mangalam Organics (NSE:MANORG) Deserve A Spot On Your Watchlist?Investors are often guided by the idea of discovering 'the next big thing', even if that means buying 'story stocks...Valuation Update With 7 Day Price Move • May 04Investor sentiment improves as stock rises 18%After last week's 18% share price gain to ₹537, the stock trades at a trailing P/E ratio of 18.4x. Average trailing P/E is 23x in the Chemicals industry in India. Total returns to shareholders of 15% over the past three years.Reported Earnings • Feb 14Third quarter 2026 earnings released: EPS: ₹5.07 (vs ₹4.26 in 3Q 2025)Third quarter 2026 results: EPS: ₹5.07 (up from ₹4.26 in 3Q 2025). Revenue: ₹1.64b (up 33% from 3Q 2025). Net income: ₹43.3m (up 19% from 3Q 2025). Profit margin: 2.6% (down from 2.9% in 3Q 2025). The decrease in margin was driven by higher expenses. Over the last 3 years on average, earnings per share has increased by 118% per year but the company’s share price has fallen by 4% per year, which means it is significantly lagging earnings.お知らせ • Feb 03Mangalam Organics Limited to Report Q3, 2026 Results on Feb 12, 2026Mangalam Organics Limited announced that they will report Q3, 2026 results on Feb 12, 2026分析記事 • Jan 15Why Investors Shouldn't Be Surprised By Mangalam Organics Limited's (NSE:MANORG) Low P/EMangalam Organics Limited's ( NSE:MANORG ) price-to-earnings (or "P/E") ratio of 16.6x might make it look like a buy...New Risk • Jan 07New minor risk - Share price stabilityThe company's share price has been volatile over the past 3 months. It is more volatile than 75% of Indian stocks, typically moving 6.9% a week. This is considered a minor risk. Share price volatility indicates the stock is highly sensitive to market conditions or economic conditions rather than being sensitive to its own business performance, which may also be inconsistent. It also increases the risk of potential losses in the short term as the stock tends to have larger drops in price more frequently than other stocks. Currently, the following risks have been identified for the company: Major Risks Interest payments are not well covered by earnings (1.4x net interest cover). Earnings have declined by 43% per year over the past 5 years. Minor Risks Share price has been volatile over the past 3 months (6.9% average weekly change). Market cap is less than US$100m (₹4.63b market cap, or US$51.6m).Valuation Update With 7 Day Price Move • Nov 19Investor sentiment deteriorates as stock falls 18%After last week's 18% share price decline to ₹445, the stock trades at a trailing P/E ratio of 16.6x. Average trailing P/E is 25x in the Chemicals industry in India. Total loss to shareholders of 17% over the past three years.お知らせ • Nov 05Mangalam Organics Limited to Report Q2, 2026 Results on Nov 14, 2025Mangalam Organics Limited announced that they will report Q2, 2026 results on Nov 14, 2025分析記事 • Aug 21Mangalam Organics Limited (NSE:MANORG) Surges 30% Yet Its Low P/E Is No Reason For ExcitementNSEI:MANORG 1 Year Share Price vs Fair Value Explore Mangalam Organics's Fair Values from the Community and select...Valuation Update With 7 Day Price Move • Aug 15Investor sentiment improves as stock rises 22%After last week's 22% share price gain to ₹551, the stock trades at a trailing P/E ratio of 20.9x. Average trailing P/E is 26x in the Chemicals industry in India. Total loss to shareholders of 2.9% over the past three years.分析記事 • Aug 14We Think Mangalam Organics (NSE:MANORG) Is Taking Some Risk With Its DebtThe external fund manager backed by Berkshire Hathaway's Charlie Munger, Li Lu, makes no bones about it when he says...Reported Earnings • Aug 09First quarter 2026 earnings released: EPS: ₹14.28 (vs ₹1.95 in 1Q 2025)First quarter 2026 results: EPS: ₹14.28 (up from ₹1.95 in 1Q 2025). Revenue: ₹1.51b (up 28% from 1Q 2025). Net income: ₹122.3m (up ₹105.6m from 1Q 2025). Profit margin: 8.1% (up from 1.4% in 1Q 2025). The increase in margin was driven by higher revenue. Over the last 3 years on average, earnings per share has increased by 57% per year but the company’s share price has fallen by 10% per year, which means it is significantly lagging earnings.お知らせ • Aug 08Mangalam Organics Limited, Annual General Meeting, Sep 16, 2025Mangalam Organics Limited, Annual General Meeting, Sep 16, 2025.お知らせ • Aug 02Mangalam Organics Limited to Report Q1, 2026 Results on Aug 08, 2025Mangalam Organics Limited announced that they will report Q1, 2026 results on Aug 08, 2025Valuation Update With 7 Day Price Move • Jul 21Investor sentiment deteriorates as stock falls 16%After last week's 16% share price decline to ₹469, the stock trades at a trailing P/E ratio of 31.7x. Average trailing P/E is 30x in the Chemicals industry in India. Total loss to shareholders of 23% over the past three years.分析記事 • Jul 19The Returns On Capital At Mangalam Organics (NSE:MANORG) Don't Inspire ConfidenceDid you know there are some financial metrics that can provide clues of a potential multi-bagger? Ideally, a business...Valuation Update With 7 Day Price Move • May 19Investor sentiment improves as stock rises 38%After last week's 38% share price gain to ₹572, the stock trades at a trailing P/E ratio of 39x. Average trailing P/E is 26x in the Chemicals industry in India. Total loss to shareholders of 17% over the past three years.分析記事 • May 16Subdued Growth No Barrier To Mangalam Organics Limited (NSE:MANORG) With Shares Advancing 32%Mangalam Organics Limited ( NSE:MANORG ) shares have continued their recent momentum with a 32% gain in the last month...New Risk • May 14New minor risk - Share price stabilityThe company's share price has been volatile over the past 3 months. It is more volatile than 75% of Indian stocks, typically moving 9.0% a week. This is considered a minor risk. Share price volatility indicates the stock is highly sensitive to market conditions or economic conditions rather than being sensitive to its own business performance, which may also be inconsistent. It also increases the risk of potential losses in the short term as the stock tends to have larger drops in price more frequently than other stocks. Currently, the following risks have been identified for the company: Major Risks Interest payments are not well covered by earnings (1.8x net interest cover). Earnings have declined by 45% per year over the past 5 years. Minor Risks Share price has been volatile over the past 3 months (9.0% average weekly change). Market cap is less than US$100m (₹4.25b market cap, or US$49.9m).Reported Earnings • May 12Full year 2025 earnings released: EPS: ₹14.60 (vs ₹5.15 in FY 2024)Full year 2025 results: EPS: ₹14.60 (up from ₹5.15 in FY 2024). Revenue: ₹5.30b (up 7.5% from FY 2024). Net income: ₹126.0m (up 186% from FY 2024). Profit margin: 2.4% (up from 0.9% in FY 2024). The increase in margin was driven by higher revenue. Over the last 3 years on average, earnings per share has fallen by 13% per year but the company’s share price has fallen by 20% per year, which means it is performing significantly worse than earnings.分析記事 • Mar 28Is Mangalam Organics (NSE:MANORG) A Risky Investment?David Iben put it well when he said, 'Volatility is not a risk we care about. What we care about is avoiding the...Valuation Update With 7 Day Price Move • Feb 21Investor sentiment improves as stock rises 25%After last week's 25% share price gain to ₹477, the stock trades at a trailing P/E ratio of 41.1x. Average trailing P/E is 25x in the Chemicals industry in India. Total loss to shareholders of 45% over the past three years.Reported Earnings • Feb 08Third quarter 2025 earnings released: EPS: ₹4.26 (vs ₹1.05 in 3Q 2024)Third quarter 2025 results: EPS: ₹4.26 (up from ₹1.05 in 3Q 2024). Revenue: ₹1.24b (up 12% from 3Q 2024). Net income: ₹36.4m (up 305% from 3Q 2024). Profit margin: 2.9% (up from 0.8% in 3Q 2024). The increase in margin was driven by higher revenue. Over the last 3 years on average, the company's share price growth rate has exceeded its earnings growth rate by 39 percentage points per year, which is a significant difference in performance.分析記事 • Sep 15Mangalam Organics Limited (NSE:MANORG) Surges 44% Yet Its Low P/S Is No Reason For ExcitementDespite an already strong run, Mangalam Organics Limited ( NSE:MANORG ) shares have been powering on, with a gain of...お知らせ • Sep 10Mangalam Organics Limited Appoints Charmi Shah as Company Secretary, Compliance Officer and Nodal Officer of the CompanyMangalam Organics Limited announced that based on the recommendation of Nomination and Remuneration Committee, the Board of Directors of the Company, at their Meeting held on September 10, 2024, has considered and approved the appointment of Ms. Charmi Shah as the Company Secretary, Compliance Officer and Nodal Officer of the Company (designated as Key Managerial Personnel) effective September 10, 2024 in terms of the Companies Act, 2013 and Rules framed thereunder and pursuant to Regulation 6 of Listing Regulations. Professional Qualification: Company Secretary and L.L.B. Academic Qualification: B.Com from Mumbai University. Work Experience: Having experience of more than 2 years in the Secretarial and Compliance field.分析記事 • Sep 05Mangalam Organics (NSE:MANORG) Seems To Use Debt Quite SensiblySome say volatility, rather than debt, is the best way to think about risk as an investor, but Warren Buffett famously...Recent Insider Transactions • Sep 03Executive Chairman recently bought ₹178m worth of stockOn the 2nd of September, Kamal Kumar Dujodwala bought around 320k shares on-market at roughly ₹557 per share. This transaction amounted to 43% of their direct individual holding at the time of the trade. This was the largest purchase by an insider in the last 3 months. This was Kamal Kumar's only on-market trade for the last 12 months.お知らせ • Aug 21+ 2 more updatesMangalam Organics Limited to Report Fiscal Year 2025 Results on May 30, 2025Mangalam Organics Limited announced that they will report fiscal year 2025 results on May 30, 2025お知らせ • Aug 12Mangalam Organics Limited, Annual General Meeting, Sep 14, 2024Mangalam Organics Limited, Annual General Meeting, Sep 14, 2024.お知らせ • Aug 10Mangalam Organics Limited Approves the Reconstitution of the CommitteesMangalam Organics Limited announce that at its board meeting held on August 10, 2024, on recommendation of the Nomination and Remuneration Committee, the Board of Directors has approved the reconstitution of the following committees, effective from August 10, 2024: Audit Committee Mrs. Manisha Agarwal – Chairperson; Mr. Sanjay Bhiva Kadam – Member; Mr. Kamalkumar Dujodwala – Member. Nomination and Remuneration Committee: Mrs. Manisha Agarwal – Chairperson; Mr. Sanjay Bhiva Kadam – Member; Mr. Kamalkumar Dujodwala – Member. Stakeholder Relationship Committee: Mrs. Manisha Agarwal – Chairperson; Mr. Sanjay Bhiva Kadam – Member; Mr. Kamalkumar Dujodwala – Member. Corporate Social Responsibility Committee: Mrs. Manisha Agarwal – Chairperson; Mr. Sanjay Bhiva Kadam – Member; Mr. Kamalkumar Dujodwala – Member.分析記事 • Aug 01Mangalam Organics Limited's (NSE:MANORG) Shares Bounce 27% But Its Business Still Trails The IndustryMangalam Organics Limited ( NSE:MANORG ) shareholders would be excited to see that the share price has had a great...Reported Earnings • Jul 27First quarter 2025 earnings released: EPS: ₹1.95 (vs ₹0.36 in 1Q 2024)First quarter 2025 results: EPS: ₹1.95 (up from ₹0.36 in 1Q 2024). Revenue: ₹1.18b (up 8.1% from 1Q 2024). Net income: ₹16.7m (up 446% from 1Q 2024). Profit margin: 1.4% (up from 0.3% in 1Q 2024). The increase in margin was driven by higher revenue.お知らせ • Jul 18Mangalam Organics Limited to Report Q1, 2025 Results on Jul 26, 2024Mangalam Organics Limited announced that they will report Q1, 2025 results on Jul 26, 2024お知らせ • Jul 15Mangalam Organics Limited Announces Resignation of Sharad Kumar Saraf as Independent DirectorMangalam Organics Limited announced that Mr. Sharad Kumar Saraf, vide letter dated July 15, 2024 has tendered his resignation as an Independent Director of the Company, with effect from close of business hours on July 15, 2024 due to other professional commitments and pre-occupations. Names of listed entities in which the resigning director holds directorships, indicating the category of directorship and membership of board committees, if any: Technocraft Industries (India) Limited: Managing Director, Member of Stakeholders Relationship Committee, Chairman of Corporate Social Responsibility, Chairman of Risk Management Committee.お知らせ • Jul 05Mangalaim Organics Limited (BSE:514418) acquired the remaining 10% stake in Mangalam Pooja Stores Private Limited from Sandeep Shriya for INR 0.1 millionMangalaim Organics Limited (BSE:514418) acquired the remaining 10% stake in Mangalam Pooja Stores Private Limited from Sandeep Shriya for INR 0.1 million on July 4, 2024.Mangalam Organics Limited (BSE:514418) completed the acquisition of the remaining 10% stake in Mangalam Pooja Stores Private Limited from Sandeep Shriya on July 4, 2024.お知らせ • Jun 13Mangalam Organics Limited Announces Resignation of Nitin Kore as Company Secretary and Compliance OfficerMangalam Organics Limited announced the resignation of Nitin Kore as Company Secretary and Compliance Officer, with effect from close of business hours of June 12, 2024, For career opportunity.Reported Earnings • Jun 04Full year 2024 earnings released: EPS: ₹5.02 (vs ₹31.79 loss in FY 2023)Full year 2024 results: EPS: ₹5.02 (up from ₹31.79 loss in FY 2023). Revenue: ₹4.94b (flat on FY 2023). Net income: ₹42.9m (up ₹315.1m from FY 2023). Profit margin: 0.9% (up from net loss in FY 2023).New Risk • May 03New minor risk - Share price stabilityThe company's share price has been volatile over the past 3 months. It is more volatile than 75% of Indian stocks, typically moving 8.4% a week. This is considered a minor risk. Share price volatility indicates the stock is highly sensitive to market conditions or economic conditions rather than being sensitive to its own business performance, which may also be inconsistent. It also increases the risk of potential losses in the short term as the stock tends to have larger drops in price more frequently than other stocks. Currently, the following risks have been identified for the company: Major Risks Interest payments are not well covered by earnings (1.5x net interest cover). Earnings have declined by 35% per year over the past 5 years. Minor Risks Unstable dividend paying track record with dividend experiencing an annual drop of over 20% in the past. Share price has been volatile over the past 3 months (8.4% average weekly change). Market cap is less than US$100m (₹3.31b market cap, or US$39.8m).分析記事 • Apr 24Mangalam Organics Limited (NSE:MANORG) Soars 30% But It's A Story Of Risk Vs RewardMangalam Organics Limited ( NSE:MANORG ) shareholders would be excited to see that the share price has had a great...Reported Earnings • Feb 10Third quarter 2024 earnings released: EPS: ₹1.05 (vs ₹0.57 in 3Q 2023)Third quarter 2024 results: EPS: ₹1.05 (up from ₹0.57 in 3Q 2023). Revenue: ₹1.11b (down 15% from 3Q 2023). Net income: ₹8.99m (up 83% from 3Q 2023). Profit margin: 0.8% (up from 0.4% in 3Q 2023). The increase in margin was driven by lower expenses.分析記事 • Jan 05Investors Holding Back On Mangalam Organics Limited (NSE:MANORG)Mangalam Organics Limited's ( NSE:MANORG ) price-to-sales (or "P/S") ratio of 0.7x might make it look like a buy right...New Risk • Nov 11New major risk - Financial positionThe company's interest payments are not well covered by earnings. Net interest cover: 1.5x This is considered a major risk. If the company is unable to fund interest repayments on its debt through profits, it may be forced into reducing its debt burden through selling assets, undertaking a potentially costly capital raising or even into bankruptcy in the worst case scenario. Currently, the following risks have been identified for the company: Major Risks Interest payments are not well covered by earnings (1.5x net interest cover). Earnings have declined by 29% per year over the past 5 years. Minor Risks Paying a dividend despite being loss-making. Market cap is less than US$100m (₹3.40b market cap, or US$40.8m).Reported Earnings • Nov 11Second quarter 2024 earnings released: EPS: ₹0.83 (vs ₹24.99 loss in 2Q 2023)Second quarter 2024 results: EPS: ₹0.83 (up from ₹24.99 loss in 2Q 2023). Revenue: ₹1.69b (up 9.5% from 2Q 2023). Net income: ₹6.31m (up ₹220.3m from 2Q 2023). Profit margin: 0.4% (up from net loss in 2Q 2023). The move to profitability was primarily driven by higher revenue.お知らせ • Oct 26+ 1 more updateMangalam Organics Limited Announces Resignation of Ms. Shachi Sanghavi as Company Secretary (Key Managerial Personnel), Compliance Officer and Nodal OfficerMangalam Organics Limited announced resignation of Ms. Shachi Sanghavi as Company Secretary (Key Managerial Personnel), Compliance Officer and Nodal Officer of the Company with effectfrom close of business hours of October 27, 2023.お知らせ • Sep 02+ 2 more updatesMangalam Organics Limited to Report Q2, 2024 Results on Nov 14, 2023Mangalam Organics Limited announced that they will report Q2, 2024 results on Nov 14, 2023Reported Earnings • Aug 12First quarter 2024 earnings released: EPS: ₹0.36 (vs ₹8.05 loss in 1Q 2023)First quarter 2024 results: EPS: ₹0.36 (up from ₹8.05 loss in 1Q 2023). Revenue: ₹1.09b (up 4.5% from 1Q 2023). Net income: ₹3.06m (up ₹72.0m from 1Q 2023). Profit margin: 0.3% (up from net loss in 1Q 2023). The move to profitability was primarily driven by higher revenue.お知らせ • Aug 12Mangalam Organics Limited, Annual General Meeting, Sep 29, 2023Mangalam Organics Limited, Annual General Meeting, Sep 29, 2023.お知らせ • Aug 04Mangalam Organics Limited to Report Q1, 2024 Results on Aug 11, 2023Mangalam Organics Limited announced that they will report Q1, 2024 results on Aug 11, 2023Reported Earnings • May 28Full year 2023 earnings released: ₹31.63 loss per share (vs ₹62.75 profit in FY 2022)Full year 2023 results: ₹31.63 loss per share (down from ₹62.75 profit in FY 2022). Revenue: ₹4.93b (flat on FY 2022). Net loss: ₹272.2m (down 151% from profit in FY 2022).お知らせ • May 19Mangalam Organics Limited to Report Fiscal Year 2023 Results on May 26, 2023Mangalam Organics Limited announced that they will report fiscal year 2023 results on May 26, 2023Reported Earnings • Jan 29Third quarter 2023 earnings released: EPS: ₹0.57 (vs ₹17.66 in 3Q 2022)Third quarter 2023 results: EPS: ₹0.57 (down from ₹17.66 in 3Q 2022). Revenue: ₹1.30b (up 11% from 3Q 2022). Net income: ₹4.92m (down 97% from 3Q 2022). Profit margin: 0.4% (down from 13% in 3Q 2022). The decrease in margin was driven by higher expenses.お知らせ • Jan 20Mangalam Organics Limited to Report Q3, 2023 Results on Jan 27, 2023Mangalam Organics Limited announced that they will report Q3, 2023 results on Jan 27, 2023お知らせ • Jan 12Mangalam Organics Limited Announces Director AppointmentsMangalam Organics Limited approved appointment of Mr. Sanjay Bhiva Kadam (DIN:09826377), as an Independent Director of the Company and the appointment of Mr. Sidharath Singh Sekhon, (DIN: 01983046), as an Independent Director of the Company.分析記事 • Nov 08Mangalam Organics (NSE:MANORG) Will Want To Turn Around Its Return TrendsFinding a business that has the potential to grow substantially is not easy, but it is possible if we look at a few key...Valuation Update With 7 Day Price Move • Nov 07Investor sentiment improved over the past weekAfter last week's 16% share price gain to ₹622, the stock trades at a trailing P/E ratio of 16.8x. Average trailing P/E is 19x in the Chemicals industry in India. Total loss to shareholders of 43% over the past year.Reported Earnings • Aug 15First quarter 2023 earnings released: ₹8.05 loss per share (vs ₹17.50 profit in 1Q 2022)First quarter 2023 results: ₹8.05 loss per share (down from ₹17.50 profit in 1Q 2022). Revenue: ₹1.05b (down 1.0% from 1Q 2022). Net loss: ₹68.9m (down 146% from profit in 1Q 2022).Valuation Update With 7 Day Price Move • Jun 20Investor sentiment deteriorated over the past weekAfter last week's 17% share price decline to ₹539, the stock trades at a trailing P/E ratio of 9.2x. Average trailing P/E is 16x in the Chemicals industry in India.Reported Earnings • May 30Full year 2022 earnings released: EPS: ₹62.68 (vs ₹99.11 in FY 2021)Full year 2022 results: EPS: ₹62.68 (down from ₹99.11 in FY 2021). Revenue: ₹4.92b (up 46% from FY 2021). Net income: ₹537.4m (down 37% from FY 2021). Profit margin: 11% (down from 25% in FY 2021). The decrease in margin was driven by higher expenses.Valuation Update With 7 Day Price Move • Feb 18Investor sentiment deteriorated over the past weekAfter last week's 18% share price decline to ₹876, the stock trades at a trailing P/E ratio of 8.8x. Average trailing P/E is 20x in the Chemicals industry in India.分析記事 • Feb 15Benign Growth For Mangalam Organics Limited (NSE:MANORG) Underpins Stock's 28% PlummetMangalam Organics Limited ( NSE:MANORG ) shareholders won't be pleased to see that the share price has had a very rough...Reported Earnings • Feb 13Third quarter 2022 earnings: Revenues and EPS in line with analyst expectationsThird quarter 2022 results: EPS: ₹17.66 (down from ₹34.65 in 3Q 2021). Revenue: ₹1.18b (up 9.1% from 3Q 2021). Net income: ₹151.2m (down 49% from 3Q 2021). Profit margin: 13% (down from 28% in 3Q 2021). The decrease in margin was driven by higher expenses. Revenue was in line with analyst estimates.分析記事 • Nov 03Mangalam Organics' (NSE:MANORG) Earnings Are Of Questionable QualityMangalam Organics Limited ( NSE:MANORG ) announced strong profits, but the stock was stagnant. Our analysis suggests...株主還元MANORGIN ChemicalsIN 市場7D9.6%1.4%0.002%1Y16.2%-3.5%-0.5%株主還元を見る業界別リターン: MANORG過去 1 年間で-3.5 % の収益を上げたIndian Chemicals業界を上回りました。リターン対市場: MANORG過去 1 年間で-0.5 % の収益を上げたIndian市場を上回りました。価格変動Is MANORG's price volatile compared to industry and market?MANORG volatilityMANORG Average Weekly Movement9.0%Chemicals Industry Average Movement6.0%Market Average Movement6.0%10% most volatile stocks in IN Market9.0%10% least volatile stocks in IN Market3.8%安定した株価: MANORGの株価は、 Indian市場と比較して過去 3 か月間で変動しています。時間の経過による変動: MANORGの weekly volatility ( 9% ) は過去 1 年間安定していますが、依然としてIndianの株式の 75% よりも高くなっています。会社概要設立従業員CEO（最高経営責任者ウェブサイト1981349Sanjay Bhardwajwww.mangalamorganics.comマンガラム・オーガニックス社は、インド国内および海外で化学品の製造・販売を行っている。同社は、樟脳、カンフェン、酢酸イソボルニル、イソボルネオール、ジペンテン、酢酸ナトリウム三水和物、樟脳油、テルピネオール、イソボルネオールフレーク、松ヤニなどのテルペン製品、テルペンフェノール樹脂、アルキルフェノール樹脂、ペンタエステルガム、グリセリン変性エステルガムなどの樹脂製品、樟脳タブレットを提供している。同社の製品は、家庭用、宗教用、ヘルスケア、衛生、繊維・染料、塗料、洗浄・脱脂剤、皮革なめし、接着剤、タイヤ、ゴム、チューインガム、印刷インキ産業で使用されている。以前はDujodwala Products Limitedとして知られていたが、2013年10月にMangalam Organics Limitedに社名変更。1981年に設立され、本社はインドのムンバイにある。もっと見るMangalam Organics Limited 基礎のまとめMangalam Organics の収益と売上を時価総額と比較するとどうか。MANORG 基礎統計学時価総額₹4.88b収益（TTM）₹257.56m売上高(TTM)₹6.23b19.0xPER（株価収益率0.8xP/SレシオMANORG は割高か？公正価値と評価分析を参照収益と収入最新の決算報告書（TTM）に基づく主な収益性統計MANORG 損益計算書（TTM）収益₹6.23b売上原価₹3.28b売上総利益₹2.95bその他の費用₹2.69b収益₹257.56m直近の収益報告Mar 31, 2026次回決算日該当なし一株当たり利益（EPS）30.07グロス・マージン47.31%純利益率4.14%有利子負債／自己資本比率111.8%MANORG の長期的なパフォーマンスは？過去の実績と比較を見るView Valuation企業分析と財務データの現状データ最終更新日（UTC時間）企業分析2026/07/21 20:53終値2026/07/21 00:00収益2026/03/31年間収益2026/03/31データソース企業分析に使用したデータはS&P Global Market Intelligence LLC のものです。本レポートを作成するための分析モデルでは、以下のデータを使用しています。データは正規化されているため、ソースが利用可能になるまでに時間がかかる場合があります。パッケージデータタイムフレーム米国ソース例会社財務10年損益計算書キャッシュ・フロー計算書貸借対照表SECフォーム10-KSECフォーム10-Qアナリストのコンセンサス予想+プラス3年予想財務アナリストの目標株価アナリストリサーチレポートBlue Matrix市場価格30年株価配当、分割、措置ICEマーケットデータSECフォームS-1所有権10年トップ株主インサイダー取引SECフォーム4SECフォーム13Dマネジメント10年リーダーシップ・チーム取締役会SECフォーム10-KSECフォームDEF 14A主な進展10年会社からのお知らせSECフォーム8-K* 米国証券を対象とした例であり、非米国証券については、同等の規制書式および情報源を使用。特に断りのない限り、すべての財務データは1年ごとの期間に基づいていますが、四半期ごとに更新されます。これは、TTM（Trailing Twelve Month）またはLTM（Last Twelve Month）データとして知られています。詳細はこちら。分析モデルとスノーフレークこのレポートを生成するために使用した分析モデルの詳細は、当社のGitHubページでご覧いただけます。また、レポートの活用方法に関するガイドやYouTubeのチュートリアルも用意しています。シンプリー・ウォールストリート分析モデルを設計・構築した世界トップクラスのチームについてご紹介します。業界およびセクターの指標私たちの業界とセクションの指標は、Simply Wall Stによって6時間ごとに計算されます。アナリスト筋Mangalam Organics Limited 0 これらのアナリストのうち、弊社レポートのインプットとして使用した売上高または利益の予想を提出したのは、 。アナリストの投稿は一日中更新されます。1 アナリスト機関Anil BurraFirstCall Research
New Risk • Jul 03New major risk - Share price stabilityThe company's share price has been highly volatile over the past 3 months. It is more volatile than 90% of Indian stocks, typically moving 9.4% a week. This is considered a major risk. Share price volatility increases the risk of potential losses in the short-term as the stock tends to have larger drops in price more frequently than other stocks. It may also indicate the stock is highly sensitive to market conditions or economic conditions rather than being sensitive to its own business performance, which may also be inconsistent. Currently, the following risks have been identified for the company: Major Risks Interest payments are not well covered by earnings (2.1x net interest cover). Share price has been highly volatile over the past 3 months (9.4% average weekly change). Earnings have declined by 38% per year over the past 5 years. Minor Risk Market cap is less than US$100m (₹4.58b market cap, or US$48.1m).
Valuation Update With 7 Day Price Move • Jun 19Investor sentiment improves as stock rises 20%After last week's 20% share price gain to ₹563, the stock trades at a trailing P/E ratio of 18.5x. Average trailing P/E is 21x in the Chemicals industry in India. Total returns to shareholders of 34% over the past three years.
Valuation Update With 7 Day Price Move • Jun 05Investor sentiment deteriorates as stock falls 19%After last week's 19% share price decline to ₹469, the stock trades at a trailing P/E ratio of 16.1x. Average trailing P/E is 21x in the Chemicals industry in India. Total returns to shareholders of 13% over the past three years.
Reported Earnings • May 31Full year 2026 earnings released: EPS: ₹29.64 (vs ₹14.71 in FY 2025)Full year 2026 results: EPS: ₹29.64 (up from ₹14.71 in FY 2025). Revenue: ₹6.27b (up 18% from FY 2025). Net income: ₹257.6m (up 105% from FY 2025). Profit margin: 4.1% (up from 2.4% in FY 2025). The increase in margin was driven by higher revenue. Over the last 3 years on average, earnings per share has increased by 108% per year but the company’s share price has only increased by 10% per year, which means it is significantly lagging earnings growth.
お知らせ • May 25Mangalam Organics Limited to Report Q4, 2026 Results on May 29, 2026Mangalam Organics Limited announced that they will report Q4, 2026 results on May 29, 2026
New Risk • May 09New minor risk - Share price stabilityThe company's share price has been volatile over the past 3 months. It is more volatile than 75% of Indian stocks, typically moving 8.7% a week. This is considered a minor risk. Share price volatility indicates the stock is highly sensitive to market conditions or economic conditions rather than being sensitive to its own business performance, which may also be inconsistent. It also increases the risk of potential losses in the short term as the stock tends to have larger drops in price more frequently than other stocks. Currently, the following risks have been identified for the company: Major Risks Interest payments are not well covered by earnings (1.4x net interest cover). Earnings have declined by 42% per year over the past 5 years. Minor Risks Share price has been volatile over the past 3 months (8.7% average weekly change). Market cap is less than US$100m (₹5.14b market cap, or US$54.4m).
New Risk • Jul 03New major risk - Share price stabilityThe company's share price has been highly volatile over the past 3 months. It is more volatile than 90% of Indian stocks, typically moving 9.4% a week. This is considered a major risk. Share price volatility increases the risk of potential losses in the short-term as the stock tends to have larger drops in price more frequently than other stocks. It may also indicate the stock is highly sensitive to market conditions or economic conditions rather than being sensitive to its own business performance, which may also be inconsistent. Currently, the following risks have been identified for the company: Major Risks Interest payments are not well covered by earnings (2.1x net interest cover). Share price has been highly volatile over the past 3 months (9.4% average weekly change). Earnings have declined by 38% per year over the past 5 years. Minor Risk Market cap is less than US$100m (₹4.58b market cap, or US$48.1m).
Valuation Update With 7 Day Price Move • Jun 19Investor sentiment improves as stock rises 20%After last week's 20% share price gain to ₹563, the stock trades at a trailing P/E ratio of 18.5x. Average trailing P/E is 21x in the Chemicals industry in India. Total returns to shareholders of 34% over the past three years.
Valuation Update With 7 Day Price Move • Jun 05Investor sentiment deteriorates as stock falls 19%After last week's 19% share price decline to ₹469, the stock trades at a trailing P/E ratio of 16.1x. Average trailing P/E is 21x in the Chemicals industry in India. Total returns to shareholders of 13% over the past three years.
Reported Earnings • May 31Full year 2026 earnings released: EPS: ₹29.64 (vs ₹14.71 in FY 2025)Full year 2026 results: EPS: ₹29.64 (up from ₹14.71 in FY 2025). Revenue: ₹6.27b (up 18% from FY 2025). Net income: ₹257.6m (up 105% from FY 2025). Profit margin: 4.1% (up from 2.4% in FY 2025). The increase in margin was driven by higher revenue. Over the last 3 years on average, earnings per share has increased by 108% per year but the company’s share price has only increased by 10% per year, which means it is significantly lagging earnings growth.
お知らせ • May 25Mangalam Organics Limited to Report Q4, 2026 Results on May 29, 2026Mangalam Organics Limited announced that they will report Q4, 2026 results on May 29, 2026
New Risk • May 09New minor risk - Share price stabilityThe company's share price has been volatile over the past 3 months. It is more volatile than 75% of Indian stocks, typically moving 8.7% a week. This is considered a minor risk. Share price volatility indicates the stock is highly sensitive to market conditions or economic conditions rather than being sensitive to its own business performance, which may also be inconsistent. It also increases the risk of potential losses in the short term as the stock tends to have larger drops in price more frequently than other stocks. Currently, the following risks have been identified for the company: Major Risks Interest payments are not well covered by earnings (1.4x net interest cover). Earnings have declined by 42% per year over the past 5 years. Minor Risks Share price has been volatile over the past 3 months (8.7% average weekly change). Market cap is less than US$100m (₹5.14b market cap, or US$54.4m).
分析記事 • May 05Does Mangalam Organics (NSE:MANORG) Deserve A Spot On Your Watchlist?Investors are often guided by the idea of discovering 'the next big thing', even if that means buying 'story stocks...
Valuation Update With 7 Day Price Move • May 04Investor sentiment improves as stock rises 18%After last week's 18% share price gain to ₹537, the stock trades at a trailing P/E ratio of 18.4x. Average trailing P/E is 23x in the Chemicals industry in India. Total returns to shareholders of 15% over the past three years.
Reported Earnings • Feb 14Third quarter 2026 earnings released: EPS: ₹5.07 (vs ₹4.26 in 3Q 2025)Third quarter 2026 results: EPS: ₹5.07 (up from ₹4.26 in 3Q 2025). Revenue: ₹1.64b (up 33% from 3Q 2025). Net income: ₹43.3m (up 19% from 3Q 2025). Profit margin: 2.6% (down from 2.9% in 3Q 2025). The decrease in margin was driven by higher expenses. Over the last 3 years on average, earnings per share has increased by 118% per year but the company’s share price has fallen by 4% per year, which means it is significantly lagging earnings.
お知らせ • Feb 03Mangalam Organics Limited to Report Q3, 2026 Results on Feb 12, 2026Mangalam Organics Limited announced that they will report Q3, 2026 results on Feb 12, 2026
分析記事 • Jan 15Why Investors Shouldn't Be Surprised By Mangalam Organics Limited's (NSE:MANORG) Low P/EMangalam Organics Limited's ( NSE:MANORG ) price-to-earnings (or "P/E") ratio of 16.6x might make it look like a buy...
New Risk • Jan 07New minor risk - Share price stabilityThe company's share price has been volatile over the past 3 months. It is more volatile than 75% of Indian stocks, typically moving 6.9% a week. This is considered a minor risk. Share price volatility indicates the stock is highly sensitive to market conditions or economic conditions rather than being sensitive to its own business performance, which may also be inconsistent. It also increases the risk of potential losses in the short term as the stock tends to have larger drops in price more frequently than other stocks. Currently, the following risks have been identified for the company: Major Risks Interest payments are not well covered by earnings (1.4x net interest cover). Earnings have declined by 43% per year over the past 5 years. Minor Risks Share price has been volatile over the past 3 months (6.9% average weekly change). Market cap is less than US$100m (₹4.63b market cap, or US$51.6m).
Valuation Update With 7 Day Price Move • Nov 19Investor sentiment deteriorates as stock falls 18%After last week's 18% share price decline to ₹445, the stock trades at a trailing P/E ratio of 16.6x. Average trailing P/E is 25x in the Chemicals industry in India. Total loss to shareholders of 17% over the past three years.
お知らせ • Nov 05Mangalam Organics Limited to Report Q2, 2026 Results on Nov 14, 2025Mangalam Organics Limited announced that they will report Q2, 2026 results on Nov 14, 2025
分析記事 • Aug 21Mangalam Organics Limited (NSE:MANORG) Surges 30% Yet Its Low P/E Is No Reason For ExcitementNSEI:MANORG 1 Year Share Price vs Fair Value Explore Mangalam Organics's Fair Values from the Community and select...
Valuation Update With 7 Day Price Move • Aug 15Investor sentiment improves as stock rises 22%After last week's 22% share price gain to ₹551, the stock trades at a trailing P/E ratio of 20.9x. Average trailing P/E is 26x in the Chemicals industry in India. Total loss to shareholders of 2.9% over the past three years.
分析記事 • Aug 14We Think Mangalam Organics (NSE:MANORG) Is Taking Some Risk With Its DebtThe external fund manager backed by Berkshire Hathaway's Charlie Munger, Li Lu, makes no bones about it when he says...
Reported Earnings • Aug 09First quarter 2026 earnings released: EPS: ₹14.28 (vs ₹1.95 in 1Q 2025)First quarter 2026 results: EPS: ₹14.28 (up from ₹1.95 in 1Q 2025). Revenue: ₹1.51b (up 28% from 1Q 2025). Net income: ₹122.3m (up ₹105.6m from 1Q 2025). Profit margin: 8.1% (up from 1.4% in 1Q 2025). The increase in margin was driven by higher revenue. Over the last 3 years on average, earnings per share has increased by 57% per year but the company’s share price has fallen by 10% per year, which means it is significantly lagging earnings.
お知らせ • Aug 08Mangalam Organics Limited, Annual General Meeting, Sep 16, 2025Mangalam Organics Limited, Annual General Meeting, Sep 16, 2025.
お知らせ • Aug 02Mangalam Organics Limited to Report Q1, 2026 Results on Aug 08, 2025Mangalam Organics Limited announced that they will report Q1, 2026 results on Aug 08, 2025
Valuation Update With 7 Day Price Move • Jul 21Investor sentiment deteriorates as stock falls 16%After last week's 16% share price decline to ₹469, the stock trades at a trailing P/E ratio of 31.7x. Average trailing P/E is 30x in the Chemicals industry in India. Total loss to shareholders of 23% over the past three years.
分析記事 • Jul 19The Returns On Capital At Mangalam Organics (NSE:MANORG) Don't Inspire ConfidenceDid you know there are some financial metrics that can provide clues of a potential multi-bagger? Ideally, a business...
Valuation Update With 7 Day Price Move • May 19Investor sentiment improves as stock rises 38%After last week's 38% share price gain to ₹572, the stock trades at a trailing P/E ratio of 39x. Average trailing P/E is 26x in the Chemicals industry in India. Total loss to shareholders of 17% over the past three years.
分析記事 • May 16Subdued Growth No Barrier To Mangalam Organics Limited (NSE:MANORG) With Shares Advancing 32%Mangalam Organics Limited ( NSE:MANORG ) shares have continued their recent momentum with a 32% gain in the last month...
New Risk • May 14New minor risk - Share price stabilityThe company's share price has been volatile over the past 3 months. It is more volatile than 75% of Indian stocks, typically moving 9.0% a week. This is considered a minor risk. Share price volatility indicates the stock is highly sensitive to market conditions or economic conditions rather than being sensitive to its own business performance, which may also be inconsistent. It also increases the risk of potential losses in the short term as the stock tends to have larger drops in price more frequently than other stocks. Currently, the following risks have been identified for the company: Major Risks Interest payments are not well covered by earnings (1.8x net interest cover). Earnings have declined by 45% per year over the past 5 years. Minor Risks Share price has been volatile over the past 3 months (9.0% average weekly change). Market cap is less than US$100m (₹4.25b market cap, or US$49.9m).
Reported Earnings • May 12Full year 2025 earnings released: EPS: ₹14.60 (vs ₹5.15 in FY 2024)Full year 2025 results: EPS: ₹14.60 (up from ₹5.15 in FY 2024). Revenue: ₹5.30b (up 7.5% from FY 2024). Net income: ₹126.0m (up 186% from FY 2024). Profit margin: 2.4% (up from 0.9% in FY 2024). The increase in margin was driven by higher revenue. Over the last 3 years on average, earnings per share has fallen by 13% per year but the company’s share price has fallen by 20% per year, which means it is performing significantly worse than earnings.
分析記事 • Mar 28Is Mangalam Organics (NSE:MANORG) A Risky Investment?David Iben put it well when he said, 'Volatility is not a risk we care about. What we care about is avoiding the...
Valuation Update With 7 Day Price Move • Feb 21Investor sentiment improves as stock rises 25%After last week's 25% share price gain to ₹477, the stock trades at a trailing P/E ratio of 41.1x. Average trailing P/E is 25x in the Chemicals industry in India. Total loss to shareholders of 45% over the past three years.
Reported Earnings • Feb 08Third quarter 2025 earnings released: EPS: ₹4.26 (vs ₹1.05 in 3Q 2024)Third quarter 2025 results: EPS: ₹4.26 (up from ₹1.05 in 3Q 2024). Revenue: ₹1.24b (up 12% from 3Q 2024). Net income: ₹36.4m (up 305% from 3Q 2024). Profit margin: 2.9% (up from 0.8% in 3Q 2024). The increase in margin was driven by higher revenue. Over the last 3 years on average, the company's share price growth rate has exceeded its earnings growth rate by 39 percentage points per year, which is a significant difference in performance.
分析記事 • Sep 15Mangalam Organics Limited (NSE:MANORG) Surges 44% Yet Its Low P/S Is No Reason For ExcitementDespite an already strong run, Mangalam Organics Limited ( NSE:MANORG ) shares have been powering on, with a gain of...
お知らせ • Sep 10Mangalam Organics Limited Appoints Charmi Shah as Company Secretary, Compliance Officer and Nodal Officer of the CompanyMangalam Organics Limited announced that based on the recommendation of Nomination and Remuneration Committee, the Board of Directors of the Company, at their Meeting held on September 10, 2024, has considered and approved the appointment of Ms. Charmi Shah as the Company Secretary, Compliance Officer and Nodal Officer of the Company (designated as Key Managerial Personnel) effective September 10, 2024 in terms of the Companies Act, 2013 and Rules framed thereunder and pursuant to Regulation 6 of Listing Regulations. Professional Qualification: Company Secretary and L.L.B. Academic Qualification: B.Com from Mumbai University. Work Experience: Having experience of more than 2 years in the Secretarial and Compliance field.
分析記事 • Sep 05Mangalam Organics (NSE:MANORG) Seems To Use Debt Quite SensiblySome say volatility, rather than debt, is the best way to think about risk as an investor, but Warren Buffett famously...
Recent Insider Transactions • Sep 03Executive Chairman recently bought ₹178m worth of stockOn the 2nd of September, Kamal Kumar Dujodwala bought around 320k shares on-market at roughly ₹557 per share. This transaction amounted to 43% of their direct individual holding at the time of the trade. This was the largest purchase by an insider in the last 3 months. This was Kamal Kumar's only on-market trade for the last 12 months.
お知らせ • Aug 21+ 2 more updatesMangalam Organics Limited to Report Fiscal Year 2025 Results on May 30, 2025Mangalam Organics Limited announced that they will report fiscal year 2025 results on May 30, 2025
お知らせ • Aug 12Mangalam Organics Limited, Annual General Meeting, Sep 14, 2024Mangalam Organics Limited, Annual General Meeting, Sep 14, 2024.
お知らせ • Aug 10Mangalam Organics Limited Approves the Reconstitution of the CommitteesMangalam Organics Limited announce that at its board meeting held on August 10, 2024, on recommendation of the Nomination and Remuneration Committee, the Board of Directors has approved the reconstitution of the following committees, effective from August 10, 2024: Audit Committee Mrs. Manisha Agarwal – Chairperson; Mr. Sanjay Bhiva Kadam – Member; Mr. Kamalkumar Dujodwala – Member. Nomination and Remuneration Committee: Mrs. Manisha Agarwal – Chairperson; Mr. Sanjay Bhiva Kadam – Member; Mr. Kamalkumar Dujodwala – Member. Stakeholder Relationship Committee: Mrs. Manisha Agarwal – Chairperson; Mr. Sanjay Bhiva Kadam – Member; Mr. Kamalkumar Dujodwala – Member. Corporate Social Responsibility Committee: Mrs. Manisha Agarwal – Chairperson; Mr. Sanjay Bhiva Kadam – Member; Mr. Kamalkumar Dujodwala – Member.
分析記事 • Aug 01Mangalam Organics Limited's (NSE:MANORG) Shares Bounce 27% But Its Business Still Trails The IndustryMangalam Organics Limited ( NSE:MANORG ) shareholders would be excited to see that the share price has had a great...
Reported Earnings • Jul 27First quarter 2025 earnings released: EPS: ₹1.95 (vs ₹0.36 in 1Q 2024)First quarter 2025 results: EPS: ₹1.95 (up from ₹0.36 in 1Q 2024). Revenue: ₹1.18b (up 8.1% from 1Q 2024). Net income: ₹16.7m (up 446% from 1Q 2024). Profit margin: 1.4% (up from 0.3% in 1Q 2024). The increase in margin was driven by higher revenue.
お知らせ • Jul 18Mangalam Organics Limited to Report Q1, 2025 Results on Jul 26, 2024Mangalam Organics Limited announced that they will report Q1, 2025 results on Jul 26, 2024
お知らせ • Jul 15Mangalam Organics Limited Announces Resignation of Sharad Kumar Saraf as Independent DirectorMangalam Organics Limited announced that Mr. Sharad Kumar Saraf, vide letter dated July 15, 2024 has tendered his resignation as an Independent Director of the Company, with effect from close of business hours on July 15, 2024 due to other professional commitments and pre-occupations. Names of listed entities in which the resigning director holds directorships, indicating the category of directorship and membership of board committees, if any: Technocraft Industries (India) Limited: Managing Director, Member of Stakeholders Relationship Committee, Chairman of Corporate Social Responsibility, Chairman of Risk Management Committee.
お知らせ • Jul 05Mangalaim Organics Limited (BSE:514418) acquired the remaining 10% stake in Mangalam Pooja Stores Private Limited from Sandeep Shriya for INR 0.1 millionMangalaim Organics Limited (BSE:514418) acquired the remaining 10% stake in Mangalam Pooja Stores Private Limited from Sandeep Shriya for INR 0.1 million on July 4, 2024.Mangalam Organics Limited (BSE:514418) completed the acquisition of the remaining 10% stake in Mangalam Pooja Stores Private Limited from Sandeep Shriya on July 4, 2024.
お知らせ • Jun 13Mangalam Organics Limited Announces Resignation of Nitin Kore as Company Secretary and Compliance OfficerMangalam Organics Limited announced the resignation of Nitin Kore as Company Secretary and Compliance Officer, with effect from close of business hours of June 12, 2024, For career opportunity.
Reported Earnings • Jun 04Full year 2024 earnings released: EPS: ₹5.02 (vs ₹31.79 loss in FY 2023)Full year 2024 results: EPS: ₹5.02 (up from ₹31.79 loss in FY 2023). Revenue: ₹4.94b (flat on FY 2023). Net income: ₹42.9m (up ₹315.1m from FY 2023). Profit margin: 0.9% (up from net loss in FY 2023).
New Risk • May 03New minor risk - Share price stabilityThe company's share price has been volatile over the past 3 months. It is more volatile than 75% of Indian stocks, typically moving 8.4% a week. This is considered a minor risk. Share price volatility indicates the stock is highly sensitive to market conditions or economic conditions rather than being sensitive to its own business performance, which may also be inconsistent. It also increases the risk of potential losses in the short term as the stock tends to have larger drops in price more frequently than other stocks. Currently, the following risks have been identified for the company: Major Risks Interest payments are not well covered by earnings (1.5x net interest cover). Earnings have declined by 35% per year over the past 5 years. Minor Risks Unstable dividend paying track record with dividend experiencing an annual drop of over 20% in the past. Share price has been volatile over the past 3 months (8.4% average weekly change). Market cap is less than US$100m (₹3.31b market cap, or US$39.8m).
分析記事 • Apr 24Mangalam Organics Limited (NSE:MANORG) Soars 30% But It's A Story Of Risk Vs RewardMangalam Organics Limited ( NSE:MANORG ) shareholders would be excited to see that the share price has had a great...
Reported Earnings • Feb 10Third quarter 2024 earnings released: EPS: ₹1.05 (vs ₹0.57 in 3Q 2023)Third quarter 2024 results: EPS: ₹1.05 (up from ₹0.57 in 3Q 2023). Revenue: ₹1.11b (down 15% from 3Q 2023). Net income: ₹8.99m (up 83% from 3Q 2023). Profit margin: 0.8% (up from 0.4% in 3Q 2023). The increase in margin was driven by lower expenses.
分析記事 • Jan 05Investors Holding Back On Mangalam Organics Limited (NSE:MANORG)Mangalam Organics Limited's ( NSE:MANORG ) price-to-sales (or "P/S") ratio of 0.7x might make it look like a buy right...
New Risk • Nov 11New major risk - Financial positionThe company's interest payments are not well covered by earnings. Net interest cover: 1.5x This is considered a major risk. If the company is unable to fund interest repayments on its debt through profits, it may be forced into reducing its debt burden through selling assets, undertaking a potentially costly capital raising or even into bankruptcy in the worst case scenario. Currently, the following risks have been identified for the company: Major Risks Interest payments are not well covered by earnings (1.5x net interest cover). Earnings have declined by 29% per year over the past 5 years. Minor Risks Paying a dividend despite being loss-making. Market cap is less than US$100m (₹3.40b market cap, or US$40.8m).
Reported Earnings • Nov 11Second quarter 2024 earnings released: EPS: ₹0.83 (vs ₹24.99 loss in 2Q 2023)Second quarter 2024 results: EPS: ₹0.83 (up from ₹24.99 loss in 2Q 2023). Revenue: ₹1.69b (up 9.5% from 2Q 2023). Net income: ₹6.31m (up ₹220.3m from 2Q 2023). Profit margin: 0.4% (up from net loss in 2Q 2023). The move to profitability was primarily driven by higher revenue.
お知らせ • Oct 26+ 1 more updateMangalam Organics Limited Announces Resignation of Ms. Shachi Sanghavi as Company Secretary (Key Managerial Personnel), Compliance Officer and Nodal OfficerMangalam Organics Limited announced resignation of Ms. Shachi Sanghavi as Company Secretary (Key Managerial Personnel), Compliance Officer and Nodal Officer of the Company with effectfrom close of business hours of October 27, 2023.
お知らせ • Sep 02+ 2 more updatesMangalam Organics Limited to Report Q2, 2024 Results on Nov 14, 2023Mangalam Organics Limited announced that they will report Q2, 2024 results on Nov 14, 2023
Reported Earnings • Aug 12First quarter 2024 earnings released: EPS: ₹0.36 (vs ₹8.05 loss in 1Q 2023)First quarter 2024 results: EPS: ₹0.36 (up from ₹8.05 loss in 1Q 2023). Revenue: ₹1.09b (up 4.5% from 1Q 2023). Net income: ₹3.06m (up ₹72.0m from 1Q 2023). Profit margin: 0.3% (up from net loss in 1Q 2023). The move to profitability was primarily driven by higher revenue.
お知らせ • Aug 12Mangalam Organics Limited, Annual General Meeting, Sep 29, 2023Mangalam Organics Limited, Annual General Meeting, Sep 29, 2023.
お知らせ • Aug 04Mangalam Organics Limited to Report Q1, 2024 Results on Aug 11, 2023Mangalam Organics Limited announced that they will report Q1, 2024 results on Aug 11, 2023
Reported Earnings • May 28Full year 2023 earnings released: ₹31.63 loss per share (vs ₹62.75 profit in FY 2022)Full year 2023 results: ₹31.63 loss per share (down from ₹62.75 profit in FY 2022). Revenue: ₹4.93b (flat on FY 2022). Net loss: ₹272.2m (down 151% from profit in FY 2022).
お知らせ • May 19Mangalam Organics Limited to Report Fiscal Year 2023 Results on May 26, 2023Mangalam Organics Limited announced that they will report fiscal year 2023 results on May 26, 2023
Reported Earnings • Jan 29Third quarter 2023 earnings released: EPS: ₹0.57 (vs ₹17.66 in 3Q 2022)Third quarter 2023 results: EPS: ₹0.57 (down from ₹17.66 in 3Q 2022). Revenue: ₹1.30b (up 11% from 3Q 2022). Net income: ₹4.92m (down 97% from 3Q 2022). Profit margin: 0.4% (down from 13% in 3Q 2022). The decrease in margin was driven by higher expenses.
お知らせ • Jan 20Mangalam Organics Limited to Report Q3, 2023 Results on Jan 27, 2023Mangalam Organics Limited announced that they will report Q3, 2023 results on Jan 27, 2023
お知らせ • Jan 12Mangalam Organics Limited Announces Director AppointmentsMangalam Organics Limited approved appointment of Mr. Sanjay Bhiva Kadam (DIN:09826377), as an Independent Director of the Company and the appointment of Mr. Sidharath Singh Sekhon, (DIN: 01983046), as an Independent Director of the Company.
分析記事 • Nov 08Mangalam Organics (NSE:MANORG) Will Want To Turn Around Its Return TrendsFinding a business that has the potential to grow substantially is not easy, but it is possible if we look at a few key...
Valuation Update With 7 Day Price Move • Nov 07Investor sentiment improved over the past weekAfter last week's 16% share price gain to ₹622, the stock trades at a trailing P/E ratio of 16.8x. Average trailing P/E is 19x in the Chemicals industry in India. Total loss to shareholders of 43% over the past year.
Reported Earnings • Aug 15First quarter 2023 earnings released: ₹8.05 loss per share (vs ₹17.50 profit in 1Q 2022)First quarter 2023 results: ₹8.05 loss per share (down from ₹17.50 profit in 1Q 2022). Revenue: ₹1.05b (down 1.0% from 1Q 2022). Net loss: ₹68.9m (down 146% from profit in 1Q 2022).
Valuation Update With 7 Day Price Move • Jun 20Investor sentiment deteriorated over the past weekAfter last week's 17% share price decline to ₹539, the stock trades at a trailing P/E ratio of 9.2x. Average trailing P/E is 16x in the Chemicals industry in India.
Reported Earnings • May 30Full year 2022 earnings released: EPS: ₹62.68 (vs ₹99.11 in FY 2021)Full year 2022 results: EPS: ₹62.68 (down from ₹99.11 in FY 2021). Revenue: ₹4.92b (up 46% from FY 2021). Net income: ₹537.4m (down 37% from FY 2021). Profit margin: 11% (down from 25% in FY 2021). The decrease in margin was driven by higher expenses.
Valuation Update With 7 Day Price Move • Feb 18Investor sentiment deteriorated over the past weekAfter last week's 18% share price decline to ₹876, the stock trades at a trailing P/E ratio of 8.8x. Average trailing P/E is 20x in the Chemicals industry in India.
分析記事 • Feb 15Benign Growth For Mangalam Organics Limited (NSE:MANORG) Underpins Stock's 28% PlummetMangalam Organics Limited ( NSE:MANORG ) shareholders won't be pleased to see that the share price has had a very rough...
Reported Earnings • Feb 13Third quarter 2022 earnings: Revenues and EPS in line with analyst expectationsThird quarter 2022 results: EPS: ₹17.66 (down from ₹34.65 in 3Q 2021). Revenue: ₹1.18b (up 9.1% from 3Q 2021). Net income: ₹151.2m (down 49% from 3Q 2021). Profit margin: 13% (down from 28% in 3Q 2021). The decrease in margin was driven by higher expenses. Revenue was in line with analyst estimates.
分析記事 • Nov 03Mangalam Organics' (NSE:MANORG) Earnings Are Of Questionable QualityMangalam Organics Limited ( NSE:MANORG ) announced strong profits, but the stock was stagnant. Our analysis suggests...
